The goals of the Radiation Biology &Imaging (RBI) Program remain unchanged since the last review of the ACC Core Grant. The RBI program seeks to improve the outcome of patients through the advanced understanding of how ionizing and non-ionizing radiation interacts with cancer and normal tissues. Through the RBI Program, investigators from diverse backgrounds and multiple Departments within the School of Medicine, Veterinary School and the School of Engineering, are brought together to identify the molecular and physiological determinants of radiation and PDT response in tumors. New areas of focus developed in the last two years include the use of nanomaterials to deliver therapeutic and imaging agents to tumors and the use of sophisticated imaging and radiation delivery approaches to better define and evaluate targets and treat tumors with the lowest possible damage to normal tissues. These new efforts have been strengthened with a substantial recruitment effort of new members into the RBI program. The programmatic goals are: 1. to understand the basic molecular mechanisms underlying the cellular response to radiation and to develop molecular targets for manipulating the response of tumors to drugs and ionizing radiation; 2. to develop clinical trials for photodynamic therapy and understand the underlying molecular and physiologic mechanisms that underlie its use; 3. to develop mechanisms to test and validate invasive and non-invasive methods for measuring tumor oxygenation and metabolic status; 4. to study the molecular events in the response to DNA damage by ionizing radiation;and 5. to develop imaging techniques that are related to the delivery and underlying mechanisms of radiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-38
Application #
8593254
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$111,965
Indirect Cost
$86,401
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Liu, Wei; Krump, Nathan A; MacDonald, Margo et al. (2018) Merkel Cell Polyomavirus Infection of Animal Dermal Fibroblasts. J Virol 92:
Schapira, Marilyn M; Barlow, William E; Conant, Emily F et al. (2018) Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment. Acad Radiol 25:1118-1127
Morrison, Alexander H; Byrne, Katelyn T; Vonderheide, Robert H (2018) Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer 4:418-428
Ojha, Rani; Leli, Nektaria M; Onorati, Angelique et al. (2018) ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma. Cancer Discov :
Yan, Lesan; Amirshaghaghi, Ahmad; Huang, Dennis et al. (2018) Protoporphyrin IX (PpIX)-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters for Magnetic Resonance Imaging and Photodynamic Therapy. Adv Funct Mater 28:
Waxman, Adam J; Clasen, Suparna; Hwang, Wei-Ting et al. (2018) Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol 4:e174519
Han, Joseph; Lachance, Catherine; Ricketts, M Daniel et al. (2018) The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate. J Biol Chem 293:4498-4509
Reshef, Ran; Ganetsky, Alex; Acosta, Edward P et al. (2018) Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biol Blood Marrow Transplant :
Gangadhar, Tara C; Savitch, Samantha L; Yee, Stephanie S et al. (2018) Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma. Pigment Cell Melanoma Res 31:73-81
Rosenfeld, Aaron M; Meng, Wenzhao; Luning Prak, Eline T et al. (2018) ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data. Front Immunol 9:2107

Showing the most recent 10 out of 1047 publications